Tetrandrine inhibits rankl-induced osteoclastogenesis by promoting the degradation of trail

HIGHLIGHTS

  • who: Jiarui Li from the Department of Orthopaedic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, No, Qingchun Road, Hangzhou, Peopleu2019s Republic of China have published the article: Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL, in the Journal: (JOURNAL)
  • what: Through the experiment , the authors aimed to explore the role of Tetrandrine in osteoclast and osteoblast formation, as well as their relationship with the TRAIL-TRAF6-NF-u03baB/ MAPKs signal axis, with the hope to determine a valuable method for preventing and treating osteoclast-related diseases.
  • how . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?